ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1431

Human TLR8 Leads to Fatal Anemia Due to Ineffective Erythropoiesis in Bone Marrow Erythroblastic Islands in Murine SLE

Naomi Maria1, Julien Papoin1, Chirag Raparia1, Zeguo Sun2, Shani Martinez1, Weijia Zhang2, Lionel Blanc1 and Anne Davidson1, 1Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 2Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: ACR Convergence 2021

Keywords: Erythropoiesis, Fatal anemia, innate immunity, Systemic lupus erythematosus (SLE), Toll Like receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Abstracts: Innate Immunity (1430–1433)

Session Type: Abstract Session

Session Time: 10:45AM-11:00AM

Background/Purpose: There are multiple causes of anemia in SLE including hemolysis, inflammation, renal insufficiency and, more rarely, microangiopathy, hemophagocytosis and bone marrow insufficiency. One cause of anemia in SLE is impaired bone marrow erythropoiesis, possibly mediated by inflammatory cytokines such as TNF or Type I interferon, or by autoantibodies. Because innate immune mechanisms are associated with anemia, here we studied the effect of TLR7 and TLR8 overexpression on SLE related anemia in an animal model in which we introduced human TLR8. Mouse and human TLR7 and human TLR8 recognize ssRNA but human TLR7 and TLR8 differ with respect to their cellular locations and the type of RNA they recognize.

Methods: Sle1.Yaa mice expressing 1-2 copies of huTLR8 as a BAC transgene (huTR8.tg) were generated and followed clinically. HuTLR8 DNA copy number and mRNA expression was confirmed by qDigital and qRT-PCR respectively. Serum autoantibodies were assessed over time. Spleen weights were assessed and splenocytes, renal and bone marrow cells were characterized by flow cytometric analysis. Mammalian erythropoiesis occurs within anatomic niches, erythroblastic islands (EBIs), where erythroblast maturation occurs by close interaction with a central macrophage. EBIs from both bone marrow and spleen were characterized by multispectral imaging flow cytometry and isolated for single cell RNA sequencing (scRNAseq) analysis.

Results: HuTLR8.tg SLE1.Yaa males expressing 2 copies of huTLR8 showed accelerated mortality by 4 months of age compared with >9 months in Sle1.Yaa and homozygous huTLR8.tg C57BL/6.Yaa controls. Complete blood counts in male SLE1.Yaa.huTLR8 mice identified severe anemia as the cause of death. This phenotype first became evident at >12 weeks of age, required both the Sle1 and Yaa loci, as well as the huTLR8 transgene and was more common and severe in huTLR8tg homozygotes. Flow cytometric analyses revealed ineffective erythropoiesis with a block at the transition from the CFU-E to proerythroblast stage. Single cell RNASeq showed that this was associated with an inflammatory phenotype in erythroblastic island central macrophages with a downregulation in adhesion and phagocytic receptors. Compensatory stress erythropoiesis in the spleen was associated with vast expansion of red pulp macrophages with phagocytic properties and fatal anemia was associated with a decrease in red blood cell (RBC) half-life, suggesting that excessive RBC phagocytosis eventually exceeds the capability of stress erythropoiesis to replace the RBC mass.

Conclusion: These data implicate huTLR8 innate inflammatory signals and the presence of auto-antibodies in defective bone marrow hematopoiesis, resulting in an altered phenotype of bone marrow EBI-associated central macrophages consequently reducing erythroid output. Furthermore, loss of mature cells through increased phagocytosis of red cells results in a fatal anemia phenotype. Further elucidating how dysregulated TLR8 signaling disrupts homeostasis of the bone marrow niche is crucial to better understand the role of this TLR in autoimmunity and will facilitate more precise therapeutic targeting.


Disclosures: N. Maria, None; J. Papoin, None; C. Raparia, None; Z. Sun, None; S. Martinez, None; W. Zhang, RenalytixAI, 1, 9; L. Blanc, None; A. Davidson, None.

To cite this abstract in AMA style:

Maria N, Papoin J, Raparia C, Sun Z, Martinez S, Zhang W, Blanc L, Davidson A. Human TLR8 Leads to Fatal Anemia Due to Ineffective Erythropoiesis in Bone Marrow Erythroblastic Islands in Murine SLE [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/human-tlr8-leads-to-fatal-anemia-due-to-ineffective-erythropoiesis-in-bone-marrow-erythroblastic-islands-in-murine-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-tlr8-leads-to-fatal-anemia-due-to-ineffective-erythropoiesis-in-bone-marrow-erythroblastic-islands-in-murine-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology